Evidence map›Paper›PMID 34265079›Full record

ArticleJournal of neurochemistry2021

Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors.

Rohan V Bhimani, Megan Vik, Ken T Wakabayashi, Caitlin Szalkowski, Caroline E Bass, Jinwoo Park

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rohan V BhimaniNeuroscience Program, University at Buffalo, State University of New York, Buffalo, NY, USA.
Megan VikDepartment of Biotechnical and Clinical Laboratory Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
Ken T WakabayashiDepartment of Biotechnical and Clinical Laboratory Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
Caitlin SzalkowskiDepartment of Biotechnical and Clinical Laboratory Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.
Caroline E BassDepartment of Pharmacology and Toxicology, University at Buffalo, State University of New York, Buffalo, NY, USA.
Jinwoo ParkNeuroscience Program, University at Buffalo, State University of New York, Buffalo, NY, USA.ORCID 0000-0001-9737-1120
University at Buffalo, State University of New York · US

Funding

Testing the Efficacy of Ibudilast to Attenuate Meth-seeking and Associated Synaptic Inflammation at the Synapse (TEAMS)P20GM130461 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI Rick A Bevins · 2019 to 2026
$20.6M
Targeted chemogenetic stimulation of rat VTA GABA neurons in cocaine extinction and reinstatementR21DA043190 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BASS, CAROLINE EVELYN · 2017 to 2018
$439k
Mapping Heterogeneous Dopamine Signaling in Subregions of the Olfactory Tubercle and Its Effect on Psychostimulant-induced BehaviorsR21DA045284 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI PARK, JINWOO · 2018 to 2019
$408k
NIDA NIH HHS R21 DA043190NIDA NIH HHS R21 DA045284NIGMS NIH HHS P20 GM130461
6 · The paper itself

Abstract

Methamphetamine (METH) is a potent psychostimulant that exerts many of its physiological and psychomotor effects by increasing extracellular dopamine (DA) concentrations in limbic brain regions. While several studies have focused on how potent, neurotoxic doses of METH augment or attenuate DA transmission, the acute effects of lower and behaviorally activating doses of METH on modulating DA regulation (release and clearance) through DA D2 autoreceptors and transporters remain to be elucidated. In this study, we investigated how systemic administration of escalating, subneurotoxic doses of METH (0.5-5 mg/kg, IP) alter extracellular DA regulation in the nucleus accumbens (NAc), in both anesthetized and awake-behaving rats through the use of in vivo fast-scan cyclic voltammetry. Pharmacological, electrochemical, and behavioral evidence show that lower doses (≤2.0 mg/kg, IP) of METH enhance extracellular phasic DA concentrations and locomotion as well as stereotypies. In contrast, higher doses (≥5.0 mg/kg) further increase both phasic and baseline DA concentrations and stereotypies but decrease horizontal locomotion. Importantly, our results suggest that acute METH-induced enhancement of extracellular DA concentrations dose dependently activates D2 autoreceptors. Therefore, these different METH dose-dependent effects on mesolimbic DA transmission may distinctly impact METH-induced behavioral changes. This study provides valuable insights regarding how low METH doses alter DA transmission and paves the way for future clinical studies on the reinforcing effects of METH.

Indexed as

AnimalsBehavior, AnimalCentral Nervous System StimulantsDopamineDopamine Uptake InhibitorsDose-Response Relationship, DrugMaleMethamphetamineMotor ActivityNeurotoxicity SyndromesNucleus AccumbensRatsRats, Sprague-DawleyReceptors, Dopamine D2Stereotyped BehaviorSynaptic TransmissionCentral Nervous System StimulantsDopamineDopamine Uptake InhibitorsMethamphetamineReceptors, Dopamine D2D2 autoreceptordopaminedose-response curveFast-scan cyclic voltammetrylocomotionmethamphetamine

Identifiers

PMID34265079
PMCPMC8376794
OpenAlexW3178063978

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.